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Background: Right entricular failure is one of the major causes of morbidity and mortality after left ventricular assist device (LVAD) 
implantation. Daily measurement of total Bilirubin(TB) is used as a marker of right heart function and its trend is plotted to ascertain 
worsening or improvement of right ventricular function. Currently predictors of prolonged inotropic use post LVAD implantation are not well 
described. We sought to identify and quantify the strength of association of a single lab value (TB≥ 4 mg/dl) and the odds of inotropic use 
ten days after LVAD implantation.
methods: From May 2012 to September 2014, 74 consecutive patients who underwent LVAD implantation at the Center for Advanced 
Heart Failure (CAHF) were included in this study. Parameters studied included patient demographics, daily serum bilirubin tests, Liver 
function tests, WBC count and Inotrope requirement until discharge or death.
results: Among the 74 patients 6 had a pre-operative TB ≥4mg/dl and 18(24.3%) patients had at least a single TB value of ≥4mg/dl in the 
first 10 days post implant. This population had an increased odds of inotropic requirement at day 10 post implant compared to patients who 
did not have even a single TB of >3.9mg/dl ( OR- 5.1 CI 1.6 -15.98 for 95% CI with p =0.003).
conclusion:  In patients with advance heart failure requiring LVAD implantation, patients having TB≥4mg/dl are more likely to be inotrope 
dependent by post-operative day 10.
Parameter Number of Patients (%)
Sex Men - 67 (90.5)Women - 7 (9.4)
Race
White - 33 (44.5)
African American - 25 (33.7)
Hispanic - 2 (2.7)
Asian - 1 (1.3)
Other - 13 (17.5)
Device
HeartMate II - 41 (55.4)
HeartWare - 21 (28.3)
HeartMate - 12 (16.2)
Destination Therapy 37 (50)
Diabetes Mellitus 23 (3.2)
Chronic Renal Failure 11 (14.8)
Pulmonary Hypertension 11 (14.8)
Coronary Artery Disease 37 (50)
